[Allogenic stem cell transplantations in lymphoma patients].
The disease recurs in a significant proportion of lymphoma patients after the first-line treatment. Intensive treatment supported by the patient's own cells (autologic stem cell transplantation) has long been utilized in selected cases, but restrictions of this form of therapy are well known. Allogenic transplantation with another person's stem cells provides a possibility to treat lymphoma having a poor prognosis even in cases where other methods of treatments have failed. Allogeneic stem cell transplantation is, however, associated with a significant risk of death.
Jantunen
Esa
E
KYS:n sisätautien klinikka, PL 1777, 70211 Kuopio.
Jyrkkiö
Sirkku
S
Kuittinen
Outi
O
Lehtinen
Tuula
T
Janes
Rita
R
Elonen
Erkki
E
Volin
Liisa
L
D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D008223:Lymphoma / Q000401:mortality* / Q000628:therapy*; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D014184:Transplantation, Homologous